Lejman, M.; Kuśmierczuk, K.; Bednarz, K.; Ostapińska, K.; Zawitkowska, J.
Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms. Int. J. Mol. Sci. 2021, 22, 9827.
https://doi.org/10.3390/ijms22189827
AMA Style
Lejman M, Kuśmierczuk K, Bednarz K, Ostapińska K, Zawitkowska J.
Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms. International Journal of Molecular Sciences. 2021; 22(18):9827.
https://doi.org/10.3390/ijms22189827
Chicago/Turabian Style
Lejman, Monika, Kinga Kuśmierczuk, Kinga Bednarz, Katarzyna Ostapińska, and Joanna Zawitkowska.
2021. "Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms" International Journal of Molecular Sciences 22, no. 18: 9827.
https://doi.org/10.3390/ijms22189827
APA Style
Lejman, M., Kuśmierczuk, K., Bednarz, K., Ostapińska, K., & Zawitkowska, J.
(2021). Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms. International Journal of Molecular Sciences, 22(18), 9827.
https://doi.org/10.3390/ijms22189827